BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35596857)

  • 1. Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.
    Zhang L; Chen Z; Li W; Liu Q; Wang Y; Chen X; Tian Z; Yang Q; An Y; Zhang Z; Mao H; Tang X; Lv G; Zhao X
    J Clin Immunol; 2022 Aug; 42(6):1280-1292. PubMed ID: 35596857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel RAC2 Mutation Causing Combined Immunodeficiency.
    Zhang L; Lv G; Peng Y; Yang L; Chen J; An Y; Zhang Z; Tang X; Li Z; Zhao X
    J Clin Immunol; 2023 Jan; 43(1):229-240. PubMed ID: 36190591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Loss of Function (G15D) Mutation on RAC2 in a Family with Combined Immunodeficiency and Increased Levels of Immunoglobulin G, A, and E.
    Duan X; Shen F; Deng Y; Zhang J; Fang F; Luo Z; Chen Y; Yang Y
    J Clin Immunol; 2023 Apr; 43(3):604-614. PubMed ID: 36459342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.
    Hsu AP; Donkó A; Arrington ME; Swamydas M; Fink D; Das A; Escobedo O; Bonagura V; Szabolcs P; Steinberg HN; Bergerson J; Skoskiewicz A; Makhija M; Davis J; Foruraghi L; Palmer C; Fuleihan RL; Church JA; Bhandoola A; Lionakis MS; Campbell S; Leto TL; Kuhns DB; Holland SM
    Blood; 2019 May; 133(18):1977-1988. PubMed ID: 30723080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAC2 and primary human immune deficiencies.
    Lougaris V; Baronio M; Gazzurelli L; Benvenuto A; Plebani A
    J Leukoc Biol; 2020 Aug; 108(2):687-696. PubMed ID: 32542921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.
    Arrington ME; Temple B; Schaefer A; Campbell SL
    J Biol Chem; 2020 Aug; 295(34):12130-12142. PubMed ID: 32636302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease.
    Smits BM; Lelieveld PHC; Ververs FA; Turkenburg M; de Koning C; van Dijk M; Leavis HL; Boelens JJ; Lindemans CA; Bloem AC; van de Corput L; van Montfrans J; Nierkens S; van Gijn ME; Geerke DP; Waterham HR; Koenderman L; Boes M
    Clin Immunol; 2020 Mar; 212():108248. PubMed ID: 31382036
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency.
    Gu Y; Jia B; Yang FC; D'Souza M; Harris CE; Derrow CW; Zheng Y; Williams DA
    J Biol Chem; 2001 May; 276(19):15929-38. PubMed ID: 11278678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections.
    Sharapova SO; Haapaniemi E; Sakovich IS; Kostyuchenko LV; Donkó A; Dulau-Florea A; Malko O; Bondarenko AV; Stegantseva MV; Leto TL; Uygun V; Karasu GT; Holland SM; Hsu AP; Aleinikova OV
    Clin Immunol; 2019 Aug; 205():1-5. PubMed ID: 31071452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency.
    Williams DA; Tao W; Yang F; Kim C; Gu Y; Mansfield P; Levine JE; Petryniak B; Derrow CW; Harris C; Jia B; Zheng Y; Ambruso DR; Lowe JB; Atkinson SJ; Dinauer MC; Boxer L
    Blood; 2000 Sep; 96(5):1646-54. PubMed ID: 10961859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ras-related C3 botulinum toxin substrate 2 (Rac2), NADPH oxidase and reactive oxygen species in diallyl disulphide-induced apoptosis of human leukaemia HL-60 cells.
    Yi L; Ji XX; Tan H; Lin M; Tang Y; Wen L; Ma YH; Su Q
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1147-53. PubMed ID: 20804509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency.
    Lagresle-Peyrou C; Olichon A; Sadek H; Roche P; Tardy C; Da Silva C; Garrigue A; Fischer A; Moshous D; Collette Y; Picard C; Casanova JL; André I; Cavazzana M
    Haematologica; 2021 Feb; 106(2):404-411. PubMed ID: 31919089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rac, a novel ras-related family of proteins that are botulinum toxin substrates.
    Didsbury J; Weber RF; Bokoch GM; Evans T; Snyderman R
    J Biol Chem; 1989 Oct; 264(28):16378-82. PubMed ID: 2674130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac2-deficient murine macrophages have selective defects in superoxide production and phagocytosis of opsonized particles.
    Yamauchi A; Kim C; Li S; Marchal CC; Towe J; Atkinson SJ; Dinauer MC
    J Immunol; 2004 Nov; 173(10):5971-9. PubMed ID: 15528331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions.
    Li S; Yamauchi A; Marchal CC; Molitoris JK; Quilliam LA; Dinauer MC
    J Immunol; 2002 Nov; 169(9):5043-51. PubMed ID: 12391220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and functional spectrum of RAC2-related immunodeficiency.
    Donkó Á; Sharapova SO; Kabat J; Ganesan S; Hauck FH; Bergerson JRE; Marois L; Abbott J; Moshous D; Williams KW; Campbell N; Martin PL; Lagresle-Peyrou C; Trojan T; Kuzmenko NB; Deordieva EA; Raykina EV; Abers MS; Abolhassani H; Barlogis V; Milla C; Hall G; Mousallem T; Church J; Kapoor N; Cros G; Chapdelaine H; Franco-Jarava C; Lopez-Lerma I; Miano M; Leiding JW; Klein C; Stasia MJ; Fischer A; Hsiao KC; Martelius T; Sepännen MRJ; Barmettler S; Walter J; Masmas TN; Mukhina AA; Falcone EL; Kracker S; Shcherbina A; Holland SM; Leto TL; Hsu AP
    Blood; 2024 Apr; 143(15):1476-1487. PubMed ID: 38194689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization.
    Shang X; Cancelas JA; Li L; Guo F; Liu W; Johnson JF; Ficker A; Daria D; Geiger H; Ratner N; Zheng Y
    J Biol Chem; 2011 Jul; 286(27):24068-78. PubMed ID: 21572048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac GTPase isoform-specific regulation of NADPH oxidase and chemotaxis in murine neutrophils in vivo. Role of the C-terminal polybasic domain.
    Yamauchi A; Marchal CC; Molitoris J; Pech N; Knaus U; Towe J; Atkinson SJ; Dinauer MC
    J Biol Chem; 2005 Jan; 280(2):953-64. PubMed ID: 15504745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders.
    Troeger A; Williams DA
    Exp Cell Res; 2013 Sep; 319(15):2375-83. PubMed ID: 23850828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D2 (PLD2) is a guanine nucleotide exchange factor (GEF) for the GTPase Rac2.
    Mahankali M; Peng HJ; Henkels KM; Dinauer MC; Gomez-Cambronero J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19617-22. PubMed ID: 22106281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.